Autobio Diagnostics Co Ltd
Autobio Diagnostics Co., Ltd. engages in the research and development, production, marketing, sale, and service of clinical diagnostic products in China and internationally. The company offers immunoassay, biochemistry, and microbiology products; reagents and instruments; and technical and support, and training services, as well as engages in biology research and development activities. Its immun… Read more
Autobio Diagnostics Co Ltd (603658) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.049x
Based on the latest financial reports, Autobio Diagnostics Co Ltd (603658) has a cash flow conversion efficiency ratio of 0.049x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥435.24 Million) by net assets (CN¥8.85 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Autobio Diagnostics Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Autobio Diagnostics Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Autobio Diagnostics Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Autobio Diagnostics Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Electricity Gnrtng NVtg
OTCGREY:EYUUF
|
0.000x |
|
NOLATO AB SER.B
F:NBF
|
N/A |
|
ADDNODE GROUP AB SK 3
F:AR7
|
N/A |
|
Wanbangde Pharmaceutical Holding Group Co Ltd
SHE:002082
|
0.000x |
|
Qurient Co. Ltd
KQ:115180
|
-0.062x |
|
PATTIES FOODS - Frankfurt Stock Exchang
F:PH4
|
N/A |
|
Nano Nuclear Energy Inc. Common Stock
NASDAQ:NNE
|
-0.022x |
|
CT Real Estate Investment Trust
PINK:CTRRF
|
0.027x |
Annual Cash Flow Conversion Efficiency for Autobio Diagnostics Co Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Autobio Diagnostics Co Ltd from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥8.69 Billion | CN¥1.31 Billion | 0.151x | -11.19% |
| 2023-12-31 | CN¥8.67 Billion | CN¥1.47 Billion | 0.170x | -13.89% |
| 2022-12-31 | CN¥7.91 Billion | CN¥1.56 Billion | 0.197x | -0.21% |
| 2021-12-31 | CN¥7.40 Billion | CN¥1.46 Billion | 0.197x | +30.67% |
| 2020-12-31 | CN¥6.59 Billion | CN¥994.71 Million | 0.151x | -52.79% |
| 2019-12-31 | CN¥2.63 Billion | CN¥842.89 Million | 0.320x | -3.79% |
| 2018-12-31 | CN¥1.97 Billion | CN¥653.73 Million | 0.333x | +16.62% |
| 2017-12-31 | CN¥1.69 Billion | CN¥481.73 Million | 0.285x | +12.80% |
| 2016-12-31 | CN¥1.64 Billion | CN¥415.82 Million | 0.253x | -41.15% |
| 2015-12-31 | CN¥718.55 Million | CN¥308.63 Million | 0.430x | -16.26% |
| 2014-12-31 | CN¥500.94 Million | CN¥256.93 Million | 0.513x | +69.15% |
| 2013-12-31 | CN¥340.42 Million | CN¥103.22 Million | 0.303x | +2.28% |
| 2012-12-31 | CN¥233.84 Million | CN¥69.32 Million | 0.296x | -8.02% |
| 2011-12-31 | CN¥156.96 Million | CN¥50.59 Million | 0.322x | -- |